Are Weight-Loss Injections The Answer To Obesity? Experts Weigh In | Health and Fitness News

Last Updated:

Are weight-loss injections the answer to obesity? Doctors explain benefits, risks, and why diet, exercise, and lifestyle still matter most.

font
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. (File pic/Reuters)

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. (File pic/Reuters)

Weight-loss injections have rapidly moved from niche medical treatments to widely discussed health tools, sparking global conversations about obesity, metabolism, and sustainable wellness. With medications that mimic the body’s appetite-regulating hormones now helping many people lose weight, interest has surged across both medical and lifestyle spaces. Yet, healthcare experts caution that while these therapies can play a role in managing obesity, they are not a replacement for the core pillars of long-term health.

According to Dr. Anju Ghei, VP and Head of Preventive Health at VLCC Healthcare, the growing popularity of these drugs has led to some misconceptions about their role in overall wellness. She says, “GLP-1 based weight-loss injections do not, in themselves, constitute a healthy lifestyle, as they pharmacologically regulate appetite without addressing the foundational behavioural, nutritional, and lifestyle patterns required for long-term metabolic health.”

Understanding How GLP-1 Weight Loss Injections Work

GLP-1–based medications mimic naturally occurring hormones that regulate appetite and blood sugar. By influencing the communication between the brain and digestive system, they help reduce hunger signals and improve metabolic control.

Dr. Sumit Aggarwal, Director and Head of Internal Medicine at Sarvodaya Hospital, Faridabad, explains that the science behind these therapies addresses deeper metabolic challenges. “These medications are not a quick solution but a biologically advanced method that helps people regain control over metabolism. In many cases, it is not a matter of lack of determination, but a hormonal miscommunication between the brain and the gut.”

By calming persistent cravings, often described as ‘food noise’, these drugs can help individuals establish healthier eating patterns while stabilising blood sugar levels.

Potential Side Effects And Safety Concerns

Despite their benefits, medical professionals stress that these treatments must be approached with caution.

Dr. Ghei notes that individuals using GLP-1 medications may experience side effects such as nausea, gastrointestinal discomfort, fatigue, or even muscle loss if lifestyle measures are not incorporated alongside treatment. Another emerging concern is the rise in unsupervised or off-label usage. With increasing online availability and social media buzz around ‘weight-loss shots,’ experts warn that misuse among individuals who do not meet medical criteria is becoming more common.

Why Lifestyle Changes Remain Essential

Even when medically appropriate, these drugs are most effective when combined with lifestyle changes. According to Dr. Aggarwal, maintaining muscle mass during weight loss is particularly important. “As these drugs can lead to rapid weight reduction, focusing on high-quality protein intake and strength training is crucial to preserve lean muscle and maintain metabolic rate,” he says.

Without such measures, individuals risk losing functional strength along with fat, potentially affecting long-term health outcomes.

Looking Beyond Rapid Weight Loss

Experts also highlight the importance of shifting the conversation from short-term weight reduction to overall metabolic health.

Dr. Nupur Jain, Physician at Kailash Hospital, Noida, emphasises that obesity is far more complex than simply carrying excess weight. “Obesity is a complex endocrine and inflammatory condition. While injectable therapies may regulate appetite signals and improve insulin dynamics, they do not correct poor diet, sedentary behaviour, chronic stress, or sleep deprivation.” She also notes that many patients approach these treatments with unrealistic expectations.

The Role Of Medical Supervision

Healthcare providers stress that weight-loss injections should always be prescribed under proper medical supervision. These therapies are typically recommended for individuals with a body mass index (BMI) of 30 or higher, or for those with obesity-related health conditions such as hypertension or diabetes.

The growing interest in weight-loss injections reflects a larger shift in how obesity and metabolic health are being understood. While GLP-1 therapies represent an important medical advancement, experts agree that they are not standalone solutions. Sustainable health still depends on a balanced diet, regular physical activity, adequate sleep, and behavioural change.

Disclaimer: Comments reflect users’ views, not News18’s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Source link

Visited 1 times, 1 visit(s) today

Related Article

3 Reasons to Sell JACK and 1 Stock to Buy Instead

3 Reasons to Sell JACK and 1 Stock to Buy Instead Since April 2026, Jack in the Box has been in a holding pattern, posting a small loss of 4.4% while floating around $12.15. The stock also fell short of the S&P 500’s 8.9% gain during that period. Is there a buying opportunity in Jack

Sports Team Value Gains Lag Stock Market Since 2022

The cost of buying a sports team has soared in recent years, including record price tags in 2026 for the Los Angeles Lakers ($12.5 billion), Seattle Seahawks ($9.34 billion) and Los Angeles Angels ($4 billion). It has spurred talk of a sports valuation bubble. Yes, sports team values are up huge, but they trail stock

Anthropic to publicly file for IPO as early as Friday, sources say

Anthropic (ANTH.PVT) is set to publicly file its S-1 investor prospectus as soon as Friday, according to three people familiar with the artificial intelligence firm’s plans. The move would mark a crucial next step for what could be the biggest IPO in history. The much-anticipated public debut, expected to surpass SpaceX’s (SPCX) June IPO, is

​Europe stands by Ukraine – but how long can that last? | World news

​Europe stands by Ukraine – but how long can that last? | World news

Europe woke up last Friday to another belligerent outburst from Donald Trump – this time berating Ukraine’s wartime leader Volodymyr Zelenskyy again. Just a few days after his diesel deal with the Kremlin, the US president said Zelenskyy was more difficult to deal with than Vladimir Putin and blamed Ukraine’s leader for rocketing oil prices

Prediction: $150 a Month Invested in Micron Stock Will Be Worth This Much by Year-End 2030

Over the last year, memory chip manufacturers have benefited from extraordinary demand for artificial intelligence (AI). In particular, Micron Technology (NASDAQ: MU) has witnessed its market capitalization propel from just $53 billion at the start of the AI revolution to more than $1 trillion today. MU Market Cap data by YCharts Missed Nvidia in 2009?

Micron Tripled in 2026. Can It Repeat in 2027?

Micron (NASDAQ: MU) stock has more than tripled so far in 2026, making it the fourth-best-performing stock in the S&P 500 (SNPINDEX: ^GSPC) this year. That’s an impressive run, but for investors, the past really doesn’t matter; only the future. So, could Micron repeat this feat in 2027? One metric suggests that the answer to

Penang among world’s top 25 places to visit in 2027

Penang has earned further international recognition in tourism after being named one of the world’s 25 best places to visit in 2027 by National Geographic, highlighting the state’s rich heritage, cultural diversity and renowned food scene. The recognition places Penang on the prestigious list of destinations recommended by the internationally acclaimed publication, making it the

GM Just Beat Earnings Estimates. Is Ford Still the Better Dividend Stock?

Quick Read Ford (F) yields nearly 5% versus GM’s (GM) sub-1%, making Ford the clear winner for investors who need cash income today. GM’s dividend is covered 18 times by free cash flow versus Ford’s 2.6 times, making GM’s payout far safer for long-term holders. GM’s stock gained 187% over ten years versus Ford’s 62%,

HKSAR govt issues travel alert for France

People walk past a looted store after violence erupted during nationwide protests against rising living costs and poor conditions in schools in Paris, Oct 19, 2026. (PHOTO/AP) HONG KONG – The Hong Kong Special Administrative Region government on Tuesday issued an amber outbound travel alert (OTA) for France. The move was made in view of

Trumpflation Is Evolving, and There’s a New Twist That Threatens to Sink Stocks

For the better part of the last four years, the stock market has been unstoppable. The artificial intelligence (AI) infrastructure build-out has helped propel the Dow Jones Industrial Average (DJINDICES:^DJI), S&P 500 (SNPINDEX:^GSPC), and Nasdaq Composite (NASDAQINDEX:^IXIC) to several record highs this year. But these gains may prove fleeting, courtesy of Trumpflation — inflation specifically

Data compiled from the International Monetary Fund’s (IMF) World Economic Outlook 2026 and World Trade Organization (WTO) trade statistics tracks economic performance around leadership changes in five countries.

Regime change doesn’t translate into economic recovery: Data

Regime change doesn’t translate into economic recovery or chart a country’s growth path, recent data from South Asia shows. Economic indicators in some South Asian countries have shown signs of gradual improvement following major political upheavals, but they have yet to fully recover, with persistent challenges regarding GDP growth, inflation and trade. Data compiled from

Hong Kong schools weigh pulling out of Paris iGEM event amid unrest in France

Several Hong Kong schools are considering withdrawing from next month’s iGEM competition in Paris amid concerns over unrest in France, as the Education Bureau stressed that student safety should remain the top priority for overseas study activities. More than 30 secondary schools and universities, involving nearly 600 students and teachers, had been scheduled to travel

Old Republic International Earnings: What To Look For From ORI

Old Republic International Earnings: What To Look For From ORI Insurance conglomerate Old Republic International (NYSE:ORI) will be reporting earnings this Thursday before market open. Here’s what investors should know. Old Republic International missed analysts’ revenue expectations last quarter, reporting revenues of $2.33 billion, up 5.2% year on year. It was a softer quarter for

Cathie Wood’s Ark Invest Grew Its Portfolio to $15.4 Billion Last Quarter, With Tesla, AMD, and a New SpaceX Stake Making Up About 18% of ARKK Assets. Is Her Concentrated Bet Paying Off?

Cathie Wood is one of America’s most-watched tech investors, known for her extreme bullishness on Bitcoin and disruptive future technologies like robotics and artificial intelligence (AI). According to her company’s most recent 13F SEC filing, as of the second quarter, Cathie Wood’s Ark Invest portfolio had a total of $15.4 billion of assets under management.

0
Would love your thoughts, please comment.x
()
x